Market Outlook - 10 June 2021 European markets finished neutral on Wednesday, with traders Unibail Rodamco rose over 6% in France, while Air France-KLM mostly avoiding accumulating positions as they awaited directional gained 3.25 percent. Sanofi, Sodexo, WorldLine, Accor, and indications from incoming U.S. inflation data and the European STMicroElectronics all ended the day higher. Central Bank's policy meeting.The release of key U.S. consumer inflation statistics on Thursday, amid much talk about increasing inflation, may provide some clues on policy tapering. The Stoxx 600 index in Europe rose 0.09 percent. The CAC 40 in In economic news, Destatis statistics indicated that Germany's France rose 0.19 percent, while the FTSE 100 in the United export growth slowed in April, gaining only 0.3 percent month-on- Kingdom fell 0.2 percent and the DAX in Germany fell 0.38 month after growing 1.3 percent in March. Economists predicted a percent. The SMI in Switzerland increased by 1.13 percent.IAG 0.5 percent increase. Imports fell by 1.7 percent in April, following a shares climbed roughly 3.25 percent in the UK market. 7.1 percent increase the month before. Economists had predicted a AstraZeneca, Smith & Nephew, GlaxoSmithKline, Informa, Just drop of 1.1 percent. Eat Takeaway, Royal Dutch Shell, Diageo, Hikma Pharmaceuticals, Relx, Compass Group, and Rolls-Royce Holdings all saw their stock prices rise by 1 to 2.5 percent. The stock of Thungela Resources has dropped 9.7%. Persimmon, In April, the trade surplus increased to EUR 15.9 billion, up from Renishaw, 3i Group, Evraz, ICP, Legal & General Group, EUR 3.5 billion in March. EUR 16.3 billion was the predicted Schroders, Anglo American Group, Barclays Group, and BHP amount. Exports increased 47.7% year over year after increasing Group all saw their stock prices drop by 2 to 3.5 percent. 16.3 percent in March, while imports increased 33.2 percent after Lufthansa and Merck both closed the day roughly 3% higher in increasing 16.2 percent. Germany. Moderate improvements were seen by Fresenius, Fresenius Medical Care, and MTU Aero Engines. Covestro's stock dropped by more than 3%. Deutsche Bank, Munich RE, HeidelbergCement, BASF, and Continental all finished the week with losses, albeit smaller ones. Top Gainers Top Losers Company Last Price Change% Company Last Price Change% arGEN-X SE €236.40 9.95% SalMar ASA kr 597.80 -5.26% Aeroports de Paris €122.70 8.15% Zalando SE € 93.80 -4.36% Swedish Orphan kr 154.60 7.29% Biovitrum Acciona S.A. € 34.80 -4.33% Galapagos N.V. € 65.57 6.62% voestalpine AG € 35.30 -3.50% Fraport AG € 61.98 6.02% Bellway PLC 3,476.00p -3.44% Market Outlook - 10 June 2021 Disclaimer and General Advice Instructions: This document is provided by Laverne Securities Pty Ltd T/as La Verne Investing the Corporate Authorized Representative No. CAR No. 001269781 of La Verne Capital Pty Ltd AFSL 482937. The Research Analyst who prepared this report/article hereby certifies that the views expressed in this document accurately reflect the analyst’s personal views about the Company and its financial products. The information provided in the Report/Article is provided by Morningstar and FactSet. La Verne Fund is not a fund manager, however, the portfolio and the document is for general advice only, prepared by the Analysts and Research team for our clients. This report/article have Different Assumptions, Views, Analytical Method of the analyst with no guarantee of reliability and accuracy of the content. The Research Analyst has not been, is not, and will not be receiving direct or indirect compensation for expressing the specific recommendations or views in this report/article. La Verne Securities has its own Research methodology, with regards to the rating and is confirmed by the team for long term Strategic rating of the concerned security as an Investment for Portfolios with High Growth High Risk Profile. Individual Stock is Speculative and of High Risk in nature and strongly This Document is provided for the Advisors, their Clients, and Financial Professionals for information only and should not be considered an offer or solicitation of an offer to buy or sell a particular security or financial product or instrument. The information or services provided in this report/article may not be suitable for you and we strongly recommend taking the advice of your Financial Planner or Investment advisors. Laverne Investing will not treat the recipients as its customer by virtue of their receiving the report/article and should seek the advice of their consultant, prior to making any investment decision considering this report/article.